Alia Mallah1, Mahmoud Amr1, Haneen Abusharkh2, Bernard Van Wie2, Arda Gozen3, Juana Mendenhall4, Edwin Tingstad5, Vincent Idone6, Nehal I Abu-Lail1. 1. Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio (UTSA), San Antonio, TX. 2. Gene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University (WSU), Pullman, WA. 3. School of Mechanical and Materials Engineering, WSU. 4. Department of Chemistry, Morehouse College, Atlanta, GA. 5. Inland Orthopedic Surgery and Sports Clinic, Pullman, WA. 6. Regeneron Pharmaceuticals Inc, Tarrytown, New York.
Abstract
INTRODUCTION: The aim of this study was to investigate the ability of osteoarthritic human chondrocytes to produce articular cartilage (AC) tissues with a reduced inflammatory environment in response to 4 anti-inflammatory nutraceuticals: alpha-tocopherol (Alpha), gallic acid (G), ascorbic acid (AA), and catechin hydrate (C). METHODS: Chondrocytes isolated from patients who underwent total knee arthroplasty surgeries were divided into groups (9 male; mean age, 66.2 ± 3.5 years and 11 female; mean age, 64.2 ± 3.1 years). Cells were cultured based on sex and supplemented with either a negative control (NC) medium or NC plus one of the nutraceuticals at a concentration of 50 μM. At day 21, cultures were characterized histologically, biochemically, and for gene expression of vital markers. RESULTS: At day 21, 62.3% and 66.2% reduction in nitric oxide (NO) content was evident for female and male cells, respectively. G-treatment of female cells resulted in the lowest expression of nitric oxide synthase-2 (NOS2), matrix metalloproteinase-13 (MMP13), and collagen type-10 (COL10). Alpha-treatment of male cells resulted in the lowest expression of NOS2, bone morphogenic protein-2, MMP13, COL10 and tumor necrosis factor alpha induced protein-6 (TNFAIP6) relative to NC. AA and Alpha treatment resulted in the highest glycosaminoglycan (GAG) content for female and male cultures, respectively. CONCLUSION: A sex-dependent response of osteoarthritic chondrocytes to nutraceutical treatment was evident. Our results suggest the use of G for female cells and Alpha for male cells in OA applications seems to be favorable in reducing inflammation and enhancing chondrocytes' ability to form AC tissues.
INTRODUCTION: The aim of this study was to investigate the ability of osteoarthritic human chondrocytes to produce articular cartilage (AC) tissues with a reduced inflammatory environment in response to 4 anti-inflammatory nutraceuticals: alpha-tocopherol (Alpha), gallic acid (G), ascorbic acid (AA), and catechin hydrate (C). METHODS: Chondrocytes isolated from patients who underwent total knee arthroplasty surgeries were divided into groups (9 male; mean age, 66.2 ± 3.5 years and 11 female; mean age, 64.2 ± 3.1 years). Cells were cultured based on sex and supplemented with either a negative control (NC) medium or NC plus one of the nutraceuticals at a concentration of 50 μM. At day 21, cultures were characterized histologically, biochemically, and for gene expression of vital markers. RESULTS: At day 21, 62.3% and 66.2% reduction in nitric oxide (NO) content was evident for female and male cells, respectively. G-treatment of female cells resulted in the lowest expression of nitric oxide synthase-2 (NOS2), matrix metalloproteinase-13 (MMP13), and collagen type-10 (COL10). Alpha-treatment of male cells resulted in the lowest expression of NOS2, bone morphogenic protein-2, MMP13, COL10 and tumor necrosis factor alpha induced protein-6 (TNFAIP6) relative to NC. AA and Alpha treatment resulted in the highest glycosaminoglycan (GAG) content for female and male cultures, respectively. CONCLUSION: A sex-dependent response of osteoarthritic chondrocytes to nutraceutical treatment was evident. Our results suggest the use of G for female cells and Alpha for male cells in OA applications seems to be favorable in reducing inflammation and enhancing chondrocytes' ability to form AC tissues.
Entities:
Keywords:
Alpha-Tocopherol; Chondrocytes; Gallic-Acid; Inflammation; Osteoarthritis; Sex
Authors: Jose Diaz-Romero; Jean Philippe Gaillard; Shawn Patrick Grogan; Dobrila Nesic; Thomas Trub; Pierre Mainil-Varlet Journal: J Cell Physiol Date: 2005-03 Impact factor: 6.384
Authors: Velandai K Srikanth; Jayne L Fryer; Guangju Zhai; Tania M Winzenberg; David Hosmer; Graeme Jones Journal: Osteoarthritis Cartilage Date: 2005-09 Impact factor: 6.576
Authors: H-G Wisniewski; E Colón; V Liublinska; R J Karia; T V Stabler; M Attur; S B Abramson; P A Band; V B Kraus Journal: Osteoarthritis Cartilage Date: 2013-12-12 Impact factor: 6.576
Authors: Victor Y L Leung; Bo Gao; Keith K H Leung; Ian G Melhado; Sarah L Wynn; Tiffany Y K Au; Nelson W F Dung; James Y B Lau; Angel C Y Mak; Danny Chan; Kathryn S E Cheah Journal: PLoS Genet Date: 2011-11-03 Impact factor: 5.917